HOME >> MEDICINE >> NEWS
A virus-like hitchhiker may trigger bacterial meningitis

Reporting in the June 20 issue of The Journal of Experimental Medicine, a group of scientists in Paris, France led by Colin Tinsley may have discovered how a normally harmless bacterium can sometimes trigger outbreaks of life-threatening meningitis.

The human body harbors many harmless bacterial residents, known as commensals. One such bacterium, called Neisseria meningitidis, makes its home in the upper respiratory tract, usually without consequence. But certain strains of N. meningitidis -- known as 'hyperinvasive' strains -- occasionally find their way into the blood stream and then into the brain, where they trigger a potentially fatal immune response (meningitis).

Tinsley and colleagues have now discovered that many hyperinvasive stains of N. meningitidis contain a bacteriophage (a virus-like organism that infects bacteria) inserted into their genetic material. The researchers studied strains of bacteria that had been isolated from humans and found that the strains that carried this virus-like stowaway were more likely to have caused disease. How this bacteriophage causes N. meningitidis to become more dangerous is unknown. It may help the bacteria get into the bloodstream, suggests Tinsley, either by altering the bacteria or by disrupting the immune response that normally protects against it.


'"/>

Contact: Nickey Henry
henryn@rockefeller.edu
212-327-8366
Journal of Experimental Medicine
20-Jun-2005


Page: 1

Related medicine news :

1. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
2. Old memory traces in brain may trigger chronic pain
3. Study implicates protein as a trigger of advanced prostate cancer recurrence
4. Chromium 6: A killer compound with an improbable trigger
5. Glucose levels trigger compensation for type 2 diabetics
6. Autoimmune disease triggered if T cells miss a single protein early on
7. Stress triggers relapse in meth abuse, OHSU study finds
8. Three molecular triggers threaten leukemia patients
9. Electric jolt triggers release of biomolecules, nanoparticles
10. Patients receiving treatment with radioisotopes may trigger security alarms
11. Drug triggers bodys mechanism to reverse aging effect on memory process

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: virus like hitchhiker may trigger bacterial meningitis

(Date:5/22/2013)... CoCENTRIX, a leading provider of coordinated ... Services and community providers, announced today that the ... CoCENTRIX Coordinated Care Platform (CoCENTRIXccp) as ... and coordinate care within and amongst its four ... transitioning the hospitals' official records from paper-based to ...
(Date:5/22/2013)... Denver, CO (PRWEB) May 22, 2013 ... of legal discovery management services for law firms, corporations ... Cumulus Data, Inc., a cloud-based e-discovery software company, to ... of this newly formed partnership, Cumulus Data and LDM ... Standard, downtown LA on Tuesday, May 21st. This ...
(Date:5/22/2013)... 2013 BroadConnect Telecom, the leading ... security solutions in North America announced plans to ... newest BroadConnect hosted security solutions. Available on premise, ... BroadConnect’s new Security as a Service (SaaS) enables ... connection of their choice, while optimizing internal network ...
(Date:5/22/2013)... Poor adherence to appropriate medication therapy has ... and death (some 125,000 deaths in the U.S. every ... costs. It’s been estimated that between 33% and 69% ... medication adherence — a reality that costs the American ... dire is the degree of medication non-adherence — and ...
(Date:5/22/2013)... Dallas, TX (PRWEB) May 22, 2013 Mari’s ... in Dallas, has become the first in the state of ... is called Meta Therapy- Medical and Esthetic Tissue Activation, also ... used for over four years in Europe, but has just ... Meta Therapy improves the skin from inside out by building ...
Breaking Medicine News(10 mins):Health News:The State of Alabama Selects the CoCENTRIX Coordinated Care Platform to Facilitate Care for Its Citizens Treated in State Psychiatric Hospitals 2Health News:The State of Alabama Selects the CoCENTRIX Coordinated Care Platform to Facilitate Care for Its Citizens Treated in State Psychiatric Hospitals 3Health News:LDM Global Enhances Forensic Data Collection Services with eCloudCollect 2Health News:LDM Global Enhances Forensic Data Collection Services with eCloudCollect 3Health News:BroadConnect Telecom to Launch Enterprise-Grade Hosted Security Solutions Engineered to Meet the Demands of Real World Business 2Health News:Patient Prompt® Announces New Drug Adherence Program to Assist in Prescribed Medication Compliance 2Health News:Mari's to Offer New Treatment from Europe 2
(Date:5/22/2013)... , May 22, 2013  Grifols, a global ... , presented results from a study demonstrating that a ... Inhibitor [Human]) increased levels of the alpha 1 ... to levels that are considered within the normal range ... condition in which low levels of the alpha 1 ...
(Date:5/22/2013)... , May 22, 2013  BD (Becton, Dickinson ... global medical technology company, announced today the publication of ... fifth Sustainability Report and it continues to focus on ... "We believe the principles of shared value — ... healthcare challenges of societies — are fundamental to our ...
(Date:5/22/2013)... , May 22, 2013 Rigel Pharmaceuticals, Inc. ... advancement of three programs in development. The first program ... inhibitor, R348, being developed by Rigel as a treatment ... aimed at oncology targets and are being conducted by ... by BerGenBio AS (BerGenBio) and a ligase inhibitor under ...
Breaking Medicine Technology:Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4BD Issues 2012 Sustainability Report 2BD Issues 2012 Sustainability Report 3Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 2Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 3Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 4
Cached News: